STAT3 and infection: Therefore, during the very early stages of infection, EBV uses a cellular mechanism (involving STAT3, caspase 7 and claspin) to block ATR-Chk1 signaling, thereby ensuring that cell proliferation would endure while viral latency gene expression gained traction (Figure 5).